Clinical Trial

Masseter Thickness, Bruxism, and Oral Behaviors in Chronic Neck Pain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated April 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
A total of 30 patients aged 18-65 years who present with chronic non-specific neck pain and 30 healthy volunteers will be included in the study. Patients with symptoms persisting for at least 3 months will be eligible for inclusion. Necessary information will be provided to all participants, and informed consent will be obtained. To assess pain severity before treatment, participants will be asked to rate their complaints using the Visual Analog Scale (VAS), a linear scale for pain assessment. The Neck Disability Index will be used to determine the level of disability. The Jaw Functional Limitation Scale-20 (JFLS-20), Patient Health Questionnaire-9 (PHQ-9), Patient Health Questionnaire-15: Physical Symptoms, Generalized Anxiety Disorder-7 (GAD-7), and the Oral Behaviors Checklist-included in Axis 2 of the DC/TMD form developed for evaluating temporomandibular joint dysfunction-will be used to assess patients' psychosocial characteristics and parafunctional habits. Additionally, masseter muscle thickness will be evaluated using ultrasonographic measurement.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-08.
Status change: Not Yet Recruiting → Recruiting 2025-03-22
Trial Details
NCT Number NCT06874816
Lead Sponsor Beylikduzu State Hospital
Conditions Neck Pain
Enrollment 60 participants
Start Date 2025-03-10
Primary Completion 2025-04-10 (estimated)
Study Completion 2025-04-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-26